TheraRadar
← Back
Data updated: Mar 29, 2026

KRAMER

Pharmaceuticals
Specialty

KRAMER is a specialty pharmaceutical company with 1 FDA-approved products.

1997
Since
1
Drugs
-
Trials
3
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

NIZORAL ANTI-DANDRUFF 2025-11-18
Labeling
NIZORAL ANTI-DANDRUFF 2025-01-26
Manufacturing (CMC)
NIZORAL ANTI-DANDRUFF 2024-07-05
Manufacturing (CMC)
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...